Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

A blood screening test for Alzheimer's disease.

O'Bryant SE, Edwards M, Johnson L, Hall J, Villarreal AE, Britton GB, Quiceno M, Cullum CM, Graff-Radford NR.

Alzheimers Dement (Amst). 2016 Jun 25;3:83-90. doi: 10.1016/j.dadm.2016.06.004. eCollection 2016.

2.

Building capacity for dementia care in Latin America and the Caribbean.

Gonzalez FJ, Gaona C, Quintero M, Chavez CA, Selga J, Maestre GE.

Dement Neuropsychol. 2014 Dec 1;8(4):310-316.

3.

Dietary antioxidant intake and its association with cognitive function in an ethnically diverse sample of US adults.

Beydoun MA, Fanelli-Kuczmarski MT, Kitner-Triolo MH, Beydoun HA, Kaufman JS, Mason MA, Evans MK, Zonderman AB.

Psychosom Med. 2015 Jan;77(1):68-82. doi: 10.1097/PSY.0000000000000129.

4.

Can Alzheimer's disease be prevented?

Murray F.

Intractable Rare Dis Res. 2013 Nov;2(4):136-8. doi: 10.5582/irdr.2013.v2.4.136.

5.

A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.

Johnson LA, Hall JR, O'Bryant SE.

PLoS One. 2013 Jul 11;8(7):e68848. doi: 10.1371/journal.pone.0068848. Print 2013.

6.

Role of grape seed polyphenols in Alzheimer's disease neuropathology.

Pasinetti GM, Ho L.

Nutr Diet Suppl. 2010 Aug 1;2010(2):97-103.

7.

Sleep complaints and incident disability in a community-based cohort study of older persons.

Park M, Buchman AS, Lim AS, Leurgans SE, Bennett DA.

Am J Geriatr Psychiatry. 2014 Jul;22(7):718-26. doi: 10.1016/j.jagp.2012.12.023. Epub 2013 Mar 25.

8.

Biomarkers of Alzheimer's disease among Mexican Americans.

O'Bryant SE, Xiao G, Edwards M, Devous M, Gupta VB, Martins R, Zhang F, Barber R; Texas Alzheimer's Research and Care Consortium (TARCC).

J Alzheimers Dis. 2013;34(4):841-9. doi: 10.3233/JAD-122074.

9.

The multilingual naming test in Alzheimer's disease: clues to the origin of naming impairments.

Ivanova I, Salmon DP, Gollan TH.

J Int Neuropsychol Soc. 2013 Mar;19(3):272-83. doi: 10.1017/S1355617712001282. Epub 2013 Jan 8.

10.

Effect of study partner on the conduct of Alzheimer disease clinical trials.

Grill JD, Raman R, Ernstrom K, Aisen P, Karlawish J.

Neurology. 2013 Jan 15;80(3):282-8. doi: 10.1212/WNL.0b013e31827debfe. Epub 2012 Dec 19.

11.

Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease.

O'Bryant SE, Johnson L, Balldin V, Edwards M, Barber R, Williams B, Devous M, Cushings B, Knebl J, Hall J.

J Alzheimers Dis. 2013;33(2):373-9. doi: 10.3233/JAD-2012-121420.

12.

Are patients whose study partners are spouses more likely to be eligible for Alzheimer's disease clinical trials?

Grill JD, Monsell S, Karlawish J.

Dement Geriatr Cogn Disord. 2012;33(5):334-40. doi: 10.1159/000339361. Epub 2012 Jul 2.

13.

Using data to improve surrogate consent for clinical research with incapacitated adults.

Abdoler E, Wendler D.

J Empir Res Hum Res Ethics. 2012 Apr;7(2):37-50. doi: 10.1525/jer.2012.7.2.37.

14.

Evidence of altered corticomotor system connectivity in early-stage Alzheimer's disease.

Vidoni ED, Thomas GP, Honea RA, Loskutova N, Burns JM.

J Neurol Phys Ther. 2012 Mar;36(1):8-16. doi: 10.1097/NPT.0b013e3182462ea6.

15.

Negotiating the joint career: couples adapting to Alzheimer's and aging in place.

Beard RL, Sakhtah S, Imse V, Galvin JE.

J Aging Res. 2012;2012:797023. doi: 10.1155/2012/797023. Epub 2011 Dec 18.

16.

Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS.

Spackman DE, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD.

Curr Alzheimer Res. 2012 Nov;9(9):1050-8.

17.

A blood-based algorithm for the detection of Alzheimer's disease.

O'Bryant SE, Xiao G, Barber R, Reisch J, Hall J, Cullum CM, Doody R, Fairchild T, Adams P, Wilhelmsen K, Diaz-Arrastia R; Texas Alzheimer’s Research and Care Consortium.

Dement Geriatr Cogn Disord. 2011;32(1):55-62. doi: 10.1159/000330750. Epub 2011 Aug 24.

18.

Differences between African American and White research volunteers in their attitudes, beliefs and knowledge regarding genetic testing for Alzheimer's disease.

Akinleye I, Roberts JS, Royal CD, Linnenbringer E, Obisesan TO, Fasaye GA, Green RC.

J Genet Couns. 2011 Dec;20(6):650-9. doi: 10.1007/s10897-011-9377-6. Epub 2011 Jun 9.

19.

Screening the methanol extracts of some Iranian plants for acetylcholinesterase inhibitory activity.

Gholamhoseinian A, Moradi MN, Sharifi-Far F.

Res Pharm Sci. 2009 Jul;4(2):105-12.

20.

Dementia risk factors for Australian baby boomers.

Panegyres PK, Gray V.

Neurol Int. 2010 Jun 21;2(1):e13. doi: 10.4081/ni.2010.e13.

Supplemental Content

Support Center